Aleksandr Nikitin

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pramana Pharmaceuticals Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aleksandr Nikitin. Retrieved from https://idiyas.com/inventor/aleksandr-nikitin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

2 out of 3

Pramana Pharmaceuticals Inc.

patents

Years Active: 2021-2024

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12037328 - Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 (2024-07-16),

2. 10906894 - Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of g protein-coupled receptor 119 (2021-02-02),

Title: Innovations by Aleksandr Nikitin

Introduction

Aleksandr Nikitin is a notable inventor based in Khimki, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors related to metabolic disorders. With a total of 2 patents, his work is paving the way for new treatments in medicine.

Latest Patents

Nikitin's latest patents focus on compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide. These compounds are recognized for their potential as agonists of G protein-coupled receptor 119. The patents detail methods and uses related to these compounds, particularly in the treatment of diseases and conditions associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders.

Career Highlights

Aleksandr Nikitin is currently associated with Pramana Pharmaceuticals Inc., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on addressing critical health issues through scientific research and development.

Collaborations

Nikitin collaborates with esteemed colleagues such as Tarek Suhayl Mansour and Mikhail Yudin. Their combined expertise enhances the research and development efforts at Pramana Pharmaceuticals Inc.

Conclusion

Aleksandr Nikitin's contributions to the field of pharmaceuticals through his innovative patents are significant. His work not only showcases his expertise but also holds promise for advancing treatments for metabolic disorders.

Profile summary based on public USPTO records.